1. Anticancer metal compounds in NCI’s tumor-screening database: putative mode of action;Huang;Biochem. Pharmacol.,2005
2. Iron chelators as anti-neoplastic agents: current developments and promise of the PIH class of chelators;Lovejoy;Curr. Med. Chem.,2003
3. Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study;Brewer;Clin. Cancer Res.,2000
4. Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer;Redman;Clin. Cancer Res.,2003
5. The Biological Chemistry of the Elements;Fraústo da Silva,2001